Discover how Australia and New Zealand (ANZ) offer a unique edge for early phase clinical trials. This webinar will highlight how ANZ enables rapid study start-up, significant cost savings, and high-quality, globally accepted data.
Watch the full webinar to learn about:
- Fast regulatory approvals (4–6 weeks) with no IND requirement
- R&D incentives and cost reductions of up to 60%
- Access to diverse patient populations and robust research infrastructure
- Strategies for integrating ANZ trials into global development plans
